National Planning Corporation’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-32,000
| Closed | -$168K | – | 89 |
|
|
2017
Q3 | $168K | Sell |
32,000
-4,000
| -11% | -$21K | 0.01% | 643 |
|
|
2017
Q2 | $210K | Sell |
36,000
-2,700
| -7% | -$15.8K | 0.02% | 661 |
|
|
2017
Q1 | $321K | Sell |
38,700
-150
| -0.4% | -$1.24K | 0.02% | 500 |
|
|
2016
Q4 | $228K | Sell |
38,850
-2,000
| -5% | -$11.7K | 0.02% | 580 |
|
|
2016
Q3 | $183K | Sell |
40,850
-150
| -0.4% | -$672 | 0.01% | 595 |
|
|
2016
Q2 | $155K | Sell |
41,000
-10,100
| -20% | -$38.2K | 0.01% | 621 |
|
|
2016
Q1 | $145K | Sell |
51,100
-200
| -0.4% | -$568 | 0.01% | 601 |
|
|
2015
Q4 | $315K | Sell |
51,300
-3,000
| -6% | -$18.4K | 0.03% | 503 |
|
|
2015
Q3 | $538K | Sell |
54,300
-9,700
| -15% | -$96.1K | 0.05% | 329 |
|
|
2015
Q2 | $732K | Sell |
64,000
-150
| -0.2% | -$1.72K | 0.07% | 275 |
|
|
2015
Q1 | $594K | Sell |
64,150
-5,900
| -8% | -$54.6K | 0.05% | 305 |
|
|
2014
Q4 | $846K | Buy |
70,050
+2,000
| +3% | +$24.1K | 0.06% | 282 |
|
|
2014
Q3 | $871K | Buy |
+68,050
| New | +$871K | 0.07% | 270 |
|